Elisabeth I. Heath

Also affiliated with Mayo Clinic in Arizona, Mayo Clinic in Florida

MedicineNursingBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/1078-0432.c.6532896

Top 100%

0DataRank

Top 100%0 citations

Archana Thakur, Wei Chen, Abhinav Deol, Meera Patel, Kimberlee Dobson +9 more

Papers

Driven by 40 papers — median percentile 0. Top paper: “Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry”.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0213-7

N/A

4.8DataRank · unranked

145 citations

Andrew J. Armstrong, Chiledum Ahaghotu, David G. McLeod, Matthew R. Cooperberg, David F. Penson +17 more

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer

JAMA Network Open(2021)10.1001/jamanetworkopen.2020.34633

N/A

2.0DataRank · unranked

43 citations

Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang +10 more

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2023)10.1016/s0140-6736(23)00913-3

N/A

1.4DataRank · unranked

49 citations

Catherine M. Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell V. Meng, Ajjai Alva +14 more

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0225

N/A

0.554DataRank · unranked

18 citations

Marianna Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth I. Heath +18 more

EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.17_suppl.lba4500

N/A

0.553DataRank · unranked

39 citations

Catherine M. Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell V. Meng, Ajjai Alva +15 more

Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1601

N/A

0.538DataRank · unranked

35 citations

Archana Thakur, Wei Chen, Abhinav Deol, Meera Patel, Kimberlee Dobson +9 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0.533DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma

Journal of Clinical Investigation(2024)10.1172/jci176230

N/A

0.524DataRank · unranked

32 citations

Pedro C. Barata, Andrew Elliott, Mehmet Asım Bilen, Earle F. Burgess, Toni K. Choueiri +16 more

Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis

Cells(2021)10.3390/cells10040802

N/A

0.505DataRank · unranked

28 citations

Hasini A. Kalpage, Junmei Wan, Asmita Vaishnav, Gargi Mahapatra, Alice A. Turner +13 more

Pan-Cancer Interrogation of B7-H3 ( CD276 ) as an Actionable Therapeutic Target Across Human Malignancies

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0546

N/A

0.500DataRank · unranked

27 citations

John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich +18 more

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00797-0

N/A

0.477DataRank · unranked

23 citations

Allison Makovec, Andrew Elliott, Samuel Kellen, John R. Lozada, Ali T. Arafa +19 more

Discovery of primary prostate cancer biomarkers using cross cancer learning

Scientific Reports(2021)10.1038/s41598-021-89789-x

N/A

0.464DataRank · unranked

21 citations

Suzan Arslanturk, Douglas B. Craig, Elisabeth Heath, Sorin Draghici, Elisabeth I. Heath +2 more

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

European Urology Open Science(2021)10.1016/j.euros.2021.09.015

N/A

0.449DataRank · unranked

19 citations

Emmanuel S. Antonarakis, Tina Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan +22 more

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0501

N/A

0.425DataRank · unranked

16 citations

Andrew Elliott, Mark G. Evans, James Wacker, Kathleen M. Storey, Emily A. Egusa +14 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509

N/A

0.425DataRank · unranked

16 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells

International Journal of Molecular Sciences(2021)10.3390/ijms22136676

N/A

0.385DataRank · unranked

12 citations

Yiwei Li, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Rachel Sexton +6 more

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0321

N/A

0.375DataRank · unranked

6 citations

Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani +16 more

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3471

N/A

0.373DataRank · unranked

11 citations

Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye +18 more

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US

Quality of Life Research(2023)10.1007/s11136-023-03468-0

N/A

0.345DataRank · unranked

9 citations

Natalie Slopen, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain, Pedro C. Barata +18 more

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

European Urology(2024)10.1016/j.eururo.2024.05.012

N/A

0.330DataRank · unranked

8 citations

Catherine M. Tangen, Elisabeth I. Heath, Shuchi Gulati, Mark N. Stein, Maxwell V. Meng +16 more

Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2563

N/A

0.208DataRank · unranked

3 citations

Justin H. Hwang, John R. Lozada, Hilary Seifert, Andrew Elliott, Milan Radovich +8 more

Experience with the US health care system for Black and White patients with advanced prostate cancer

Cancer(2023)10.1002/cncr.34885

N/A

0.104DataRank · unranked

1 citations

Konrad H. Stopsack, Natalie Slopen, Folakemi T. Odedina, Camille Ragin, Joel Nowak +11 more

Data from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/1078-0432.c.6532896

Top 100%

0DataRank

Top 100%0 citations

Archana Thakur, Wei Chen, Abhinav Deol, Meera Patel, Kimberlee Dobson +9 more

1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2781

N/A

0DataRank · unranked

0 citations

M.L. Zahurek, Adel Mandl, Michelle A. Rudek, Elisabeth I. Heath, Catherine H. Marshall +13 more

Data from Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition

(2023)10.1158/0008-5472.c.6497498

N/A

0DataRank · unranked

0 citations

Sang Y. Chun, Kyunghee Burkitt, Masako Abe, Shaowei Chen, Pamela A. Havre +10 more

Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer

Theranostics(2023)10.7150/thno.78915

N/A

0DataRank · unranked

3 citations

Nicholas Ramos, Allen-Dexter Saliganan, Joon‐Yong Chung, Meghan M. Bell, Jacob Lindquist +9 more

PACCT: An intervention to improve communication quality and clinical trial invitations for Black and White men with prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e24137

N/A

0DataRank · unranked

0 citations

Nicole Senft, Seongho Kim, Hyejeong Jang, Mark Manning, Tanina Foster +6 more

Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies

Frontiers in Genetics(2022)10.3389/fgene.2022.1015531

N/A

0DataRank · unranked

12 citations

Tasnimul Alam Taz, Suzan Arslanturk, Elisabeth I. Heath, Seeya Awadhut Munj

Physicians’ use of plain language during discussions of prostate cancer clinical trials with patients

Patient Education and Counseling(2022)10.1016/j.pec.2022.09.002

N/A

0DataRank · unranked

15 citations

Lauren M. Hamel, Fatmeh Baidoun, Tanina Foster Moore, Ellen Barton, Elisabeth I. Heath +4 more

Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells

Biomolecules(2024)10.3390/biom14060695

N/A

0DataRank · unranked

8 citations

Junmei Wan, Tasnim Arroum, Mackenzie K. Herroon, Hasini A. Kalpage, Viktoriia Bazylianska +5 more

Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0439

N/A

0DataRank · unranked

7 citations

Vincent M. D’Anniballe, David Boczkowski, Harini Kandadi, Nadeem A. Sheikh, William Kornahrens +10 more

From community to validated measure: Development and validation of the patient-informed cancer communication scale (PICCS).

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.159

N/A

0DataRank · unranked

0 citations

Roger Soulliere, Fatmeh Baidoun, Tanina Foster, Elisabeth I. Heath, Susan Eggly +1 more

A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100679

N/A

0DataRank · unranked

12 citations

Lance K. Heilbrun, Jordan Maier, Kiran Devisetty, Irene Connolly, Isaac Kaufman +7 more

Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5085

N/A

0DataRank · unranked

2 citations

Irene Tsung, Jessica Lee, Lincoln W. Pasquina, Amy Kasputis, Jennie L. Lovett +6 more

A Ten Year Experience of Men’s Health Events in a Socioeconomically Diverse City in the United States – Lessons Learned

Journal of Community Health(2024)10.1007/s10900-024-01354-5

N/A

0DataRank · unranked

0 citations

Navid Mahabadi, Lauren M. Hamel, Gregory Dyson, Michael Lutz, Andrea L. Hamilton +3 more

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00237-1

N/A

0DataRank · unranked

106 citations

Jae Eun Choi, Jean C. Tien, Stephanie A. Simko, Thekkelnaycke M. Rajendiran, Josh N. Vo +29 more

Phase II trial of a novel immunotherapy combination of pembrolizumab and HER2 bi-armed activated T cells (BATs) in metastatic castrate resistant prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.97

N/A

0DataRank · unranked

6 citations

Lawrence G. Lum, Abhinav Deol, Archana Thakur, Elisabeth I. Heath, Wei Chen +4 more

Detecting TRA-1–60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent

Molecular Pharmaceutics(2020)10.1021/acs.molpharmaceut.9b01181

N/A

0DataRank · unranked

7 citations

Akhila N. W. Kuda‐Wedagedara, Madison N. Wicker, Daniel E. Spratt, William M. Schopperle, Elisabeth I. Heath +2 more

Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors

Journal of Pain and Symptom Management(2025)10.1016/j.jpainsymman.2025.04.016

N/A

0DataRank · unranked

2 citations

Miguel Muniz, Candy S Peskey, Aminah Jatoi, Kathryn J. Ruddy, Jacob J. Orme +14 more

Elisabeth I. Heath

Indexed papers

Top data-sharing exemplar

Papers